kff glp-1 KFF's survey of Medicaid officials found 16 state Medicaid programs covered GLP-1s for obesity treatment as of October 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC In Mississippi, Weight Loss Drug

The distinction between ingredient-level findings and product-level clinical proof applies here as it does across the broader supplement category

Instead it suggests you go directly to the medication manufacturer site for pricing information

These dietary changes alone may alter stool characteristics

We emphasize the importance of compassionate care and support throughout the treatment process

In contrast, health plans are more likely to evaluate obesity treatment through the lens of clinical effectiveness balanced with cost-efficiency, considering the large percentage of members who would be eligible to take the drugs